Search results for "L. Bueno. Mechanisms involved in bacterial pathogen-induced intestinal mucosal barrier disruption: Therapeutic interest of mecha"

  A new class of non-drug treatments for rhinitis of various origins is gaining momentum. Among them, Xyloglucan stands out as a natural substance with a well-defined mode of action: its mechanical barrier effect (1) can help in the control of the symptoms of rhinitis by preventing allergens, pathogens and pollutants coming into contact with the nasal mucosa (1, 2).
Beneficial effect of the combination of pea protein and grape seed extract in a murine model of vulvovaginal candidiasis.
We are pleased to announce the launch of UTIPRO® PLUS AF in Portugal.
BMC Gastroenterology (2015) 15:153 Background: There is a strong rationale for the use of agents with film-forming protective properties, like xyloglucan, for the treatment of acute diarrhea. However, few data from clinical trials are available.
Expert Opin Investig Drugs. 2017 Dec 26:1-6.  
Noventure is glad to announce the launch of TASECTAN® AF in Denmark by its partner company Pharmaforce, thus setting a record time-to-market, after Noventure granted Pharmaforce exclusive distribution right for Tasectan® AF in the Nordic markets last April.
After the publication of the first paper in which the significant antioxidant activity of Olea europaea leaf extract (OELE) was observed and assessed, we are happy to announce the second publication related to the hydrogel (EHO-85) based on OELE, indicated for the healing of wounds of full and partial thickness.